Genmab — Oktober 2017
-
Hvordan har salget for de øvrige lægemidler (konkurrenter) til behandling af myelomatose udviklet sig i Q3 i USA, nogen der ved det?
-
velcade FALDT 10%
-
men det var i ROW
-
det er godt nok heftig volume i disse dage
-
ja, man kan godt få lidt bange anelser for at nogle af de store har skiftet mening
-
Tak Mobbyduck1! Hvad med Pomalyst og Kyprolis?
-
tror ikke de er ude endnu
-
Tak, god dag!

-
speaking of basics - her er et lille baggrundsskriv omkring MM markedet https://www.openpr.com/news/776135/Multiple-Myeloma-Treatment-Market-Shares-Strategies-and-Forecast-Worldwide-2017-to-2025.html
-
celgeneq3 kommer 26 okt
-
amgen kommer dagen før
-
Mange tak, JørgenVarnæs
-
Dr. Jan van de Winkel Joins Hookipa as Chairman of its Board of Directors - http://www.businesswire.com/news/home/20171018005677/en/Dr.-Jan-van-de-Winkel-Joins-Hookipa
-
Legolas: Den krystalkugle vil jeg gerne låne

-
Det er på dage som i dag og i går, at det bliver helt åbenbart, hvor stort et problem nasdaqs censur er for os retail investorer
-
jeg kiggede lidt på den seneste investorpræsentation fra GEN http://files.shareholder.com/downloads/AMDA-KPIBN/4613191470x0x956779/5BB3036D-BB67-4C1F-A273-265DD2A1F676/Investor_prestn_September_v080917v2.pdf
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind